1. Home
  2. VTYX vs RELL Comparison

VTYX vs RELL Comparison

Compare VTYX & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • RELL
  • Stock Information
  • Founded
  • VTYX 2018
  • RELL 1947
  • Country
  • VTYX United States
  • RELL United States
  • Employees
  • VTYX N/A
  • RELL N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • RELL Electronic Components
  • Sector
  • VTYX Health Care
  • RELL Technology
  • Exchange
  • VTYX Nasdaq
  • RELL Nasdaq
  • Market Cap
  • VTYX 184.6M
  • RELL 202.2M
  • IPO Year
  • VTYX 2021
  • RELL N/A
  • Fundamental
  • Price
  • VTYX $2.30
  • RELL $13.77
  • Analyst Decision
  • VTYX Buy
  • RELL
  • Analyst Count
  • VTYX 5
  • RELL 0
  • Target Price
  • VTYX $8.40
  • RELL N/A
  • AVG Volume (30 Days)
  • VTYX 2.3M
  • RELL 65.7K
  • Earning Date
  • VTYX 11-07-2024
  • RELL 01-08-2025
  • Dividend Yield
  • VTYX N/A
  • RELL 1.71%
  • EPS Growth
  • VTYX N/A
  • RELL N/A
  • EPS
  • VTYX N/A
  • RELL N/A
  • Revenue
  • VTYX N/A
  • RELL $197,604,000.00
  • Revenue This Year
  • VTYX N/A
  • RELL $15.93
  • Revenue Next Year
  • VTYX N/A
  • RELL $11.34
  • P/E Ratio
  • VTYX N/A
  • RELL N/A
  • Revenue Growth
  • VTYX N/A
  • RELL N/A
  • 52 Week Low
  • VTYX $1.67
  • RELL $8.08
  • 52 Week High
  • VTYX $11.48
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 47.68
  • RELL 42.82
  • Support Level
  • VTYX $2.21
  • RELL $13.82
  • Resistance Level
  • VTYX $2.54
  • RELL $15.51
  • Average True Range (ATR)
  • VTYX 0.27
  • RELL 0.52
  • MACD
  • VTYX -0.05
  • RELL -0.08
  • Stochastic Oscillator
  • VTYX 8.02
  • RELL 21.24

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

Share on Social Networks: